Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
8 pending office actions • 5 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready
FULWIDER PATTON LLP has 8 pending office actions in Medical Devices & Mechanical Engineering. Its career record includes 4064 applications, indicating extensive historical activity in addition to the current matters.
The resolved allowance rate is 81.07%, with an average of 2.91 office actions per allowance. Practitioners can use the allowance figure to understand resolved outcomes and the action average to anticipate the level of examination interaction represented by the record.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| Double-patenting only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, DIEM M | 1 | 80.1% | +13.5% |
| SHIM, MORGAN SANGJO | 1 | 0.0% | +0.0% |
| LARSEN, JEFFREY R | 1 | 39.5% | +38.1% |
| HENSON, DEVIN B | 1 | 65.1% | +43.4% |
| PRESTON, REBECCA STRASZHEIM | 1 | 74.0% | +38.3% |
| ANDERSON-FEARS, KEENAN NEIL | 1 | 15.4% | +37.5% |
| CERIONI, DANIEL LEE | 1 | 64.3% | +28.0% |
| SHARMA, SANTOSH | 1 | 72.8% | +29.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19009480 | COLLAPSIBLE SHIPPING CONTAINER ACTUATING SYSTEM | TRAN, DIEM M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18954104 | GUIDEWIRE AND METHOD OF USE | SHIM, MORGAN SANGJO | — |
| 18914029 | A METHOD FOR CONVERSION OF LEGACY TRUCKS TO ELECTRICAL POWER | LARSEN, JEFFREY R | — |
| 18633933 | INTRAVASCULAR STENT | PRESTON, REBECCA STRASZHEIM | — |
| 18213157 | SELF-DESIGNED SINGLE-NUCLEOTIDE POLYMORPHISM CHIP AND METHOD OF COMPUTING POLYGENICRISK SCORE FOR GIVEN POPULATIONS USING SELF-DESIGNED SINGLE-NUCLEOTIDE POLYMORPHISM CHIP | ANDERSON-FEARS, KEENAN NEIL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19009480 | COLLAPSIBLE SHIPPING CONTAINER ACTUATING SYSTEM | TRAN, DIEM M | — |
| 18914029 | A METHOD FOR CONVERSION OF LEGACY TRUCKS TO ELECTRICAL POWER | LARSEN, JEFFREY R | — |
| 18912303 | GUIDE WIRE TIP HAVING ROUGHENED SURFACE | HENSON, DEVIN B | — |
| 18633933 | INTRAVASCULAR STENT | PRESTON, REBECCA STRASZHEIM | — |
| 18213157 | SELF-DESIGNED SINGLE-NUCLEOTIDE POLYMORPHISM CHIP AND METHOD OF COMPUTING POLYGENICRISK SCORE FOR GIVEN POPULATIONS USING SELF-DESIGNED SINGLE-NUCLEOTIDE POLYMORPHISM CHIP | ANDERSON-FEARS, KEENAN NEIL | — |
| 18196283 | TWISTED GUIDEWIRE | CERIONI, DANIEL LEE | — |
| 17982444 | METHOD FOR PRODUCING SUGAR FROM AGAVE CULTURES | SHARMA, SANTOSH | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Abbott Laboratories | 4 |
| Genflat Holdings Inc. | 1 |
| Astrolectric LLC | 1 |
| Genestory Joint Stock Company | 1 |
| Phytoteq, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 3654 | 1 |
| 3612 | 1 |
| 3774 | 1 |
| 1687 | 1 |
| 1663 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19009480 | COLLAPSIBLE SHIPPING CONTAINER ACTUATING SYSTEM | Genflat Holdings Inc. | TRAN, DIEM M | 3654 | §103 | Non-Final OA | — | Pending | Jan 03, 2025 |
| 18954104 | GUIDEWIRE AND METHOD OF USE | Abbott Cardiovascular Systems Inc. | SHIM, MORGAN SANGJO | 3791 | §102§103§112Other | Non-Final OA | — | Pending | Nov 20, 2024 |
| 18914029 | A METHOD FOR CONVERSION OF LEGACY TRUCKS TO ELECTRICAL POWER | Astrolectric LLC | LARSEN, JEFFREY R | 3612 | §103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18912303 | GUIDE WIRE TIP HAVING ROUGHENED SURFACE | Abbott Cardiovascular Systems Inc. | HENSON, DEVIN B | 3791 | DP | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18633933 | INTRAVASCULAR STENT | Abbott Cardiovascular Systems Inc. | PRESTON, REBECCA STRASZHEIM | 3774 | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18213157 | SELF-DESIGNED SINGLE-NUCLEOTIDE POLYMORPHISM CHIP AND METHOD OF COMPUTING POLYGENICRISK SCORE FOR GIVEN POPULATIONS USING SELF-DESIGNED SINGLE-NUCLEOTIDE POLYMORPHISM CHIP | Genestory Joint Stock Company | ANDERSON-FEARS, KEENAN NEIL | 1687 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18196283 | TWISTED GUIDEWIRE | Abbott Cardiovascular Systems Inc. | CERIONI, DANIEL LEE | 3791 | §103 | Non-Final OA | — | Pending | May 11, 2023 |
| 17982444 | METHOD FOR PRODUCING SUGAR FROM AGAVE CULTURES | Phytoteq, Inc. | SHARMA, SANTOSH | 1663 | §103DP | Non-Final OA | — | Pending | Nov 07, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.1% of resolved applications prosecuted by Fulwider Patton LLP were allowed, across 4,064 applications in USPTO records.
2.91 office actions per allowed application on average.
8 pending office actions as of October 2026, for 5 clients, before 8 examiners in 6 art units.
